Home › IBB Has A Formidable Challenger In BBP
 

Keywords :   


IBB Has A Formidable Challenger In BBP

2015-05-30 10:41:58| Biotech - Topix.net

A pure biotech ETF, BBP has entered the investment sphere that focuses on the biotechnology cohort with at least one FDA approved product. BBP is a pure biotech play with no holdings in the generic or specialty pharma, life science tools, medical device/diagnostic, or other healthcare companies.

Tags: in formidable challenger

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
27.09Washington Corner | September 2024
27.09Hurricane Isaac Graphics
27.09Remnants of John Graphics
27.09Remnants of John Forecast Discussion Number 20
27.09Remnants of John Wind Speed Probabilities Number 20
27.09Remnants of John Public Advisory Number 20
27.09Summary for Remnants of John (EP5/EP102024)
27.09Tropical Storm Joyce Graphics
More »